Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09

Meeting ID: 958 6960 8121
Passcode: 636276

Robert James McDonald, M.D., Ph.D.
"Recommendations and Updates on Contrast Agent Use: Keeping Your Practice Up To Date "

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Identify role and utilization of contrast media in clinical practice.
• Recognize risk factors for and adverse events associated with contrast administration and appropriate risk mitigation strategies.
• Review recent changes in recommendations for GBCA use among patients with renal impairment.
• Summarize existing and emerging data on prophylaxis of allergic-like reactions to contrast media.
• Review recommendations regarding use of GBCA agents in pregnant women.
• Summarize existing and emerging data on gadolinium tissue deposition and the clinical significance of this phenomenon.

Dr. McDonald does have the following relevant financial relationships to disclose: Consultant – GEHealthcare; US Food and Drug Administration; Bracco diagnostics. Grant/Research - GEHealthcare; Bayer Healthcare. Other- Committee Member - American College of Radiology.  He does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.